Biotech Values

[jbog]

Tecfidera’s first week

It’s hard to know the extent to which the strong script sales in the first week is indicative of future sales rather than the widespread publicity about the drug in the past few months.

How about the 3rd week?

Biogen MS drug scripts show 120% week-over-week gain,Leerink says third-week scripts for Biogen's multiple sclerosis drug Tecfidera were strong with a 120% increase week-over-week.

I'm hearing that the only snag is the paperwork at this point.